Leveljump Healthcare Corp. Acquires Additional 10.44% of Real Time Medical Inc.

Toronto, Ontario--(Newsfile Corp. - April 26, 2022) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has entered into an agreement (the "Purchase Agreement") which will result in the Company acquiring control over an additional 10.44% of Real Time Medical Inc. ("RTM"). Under the terms of the Purchase Agreement, the Company has agreed to acquire from an arm's length vendor all of the outstanding shares of 7127651 Canada Inc. ("712"), a private Nova Scotia based federal corporation. 712 is a holding company with its principal asset being 1,784,364 common shares of Real Time Medical Inc. The Company has agreed to pay to the vendor total consideration of $963,556.56 consisting of: (i) cash in the amount of $579,918 payable in 3 instalments over four months; and (ii) 2,557,590 common shares of the Company (the "Consideration Shares") at a deemed issue price of $0.15 per share with an aggregate value of $383,638.56. One-half of the Consideration Shares will be subject to a contractual hold period of 180 days from closing with the balance of the Consideration Shares releasable one year after closing.

In addition to the purchase of the shares of 712, the Company has agreed to purchase from the vendor for the sum of $50,000, a promissory note of RTM in the principal amount of $50,000 with any accrued interest.

Upon closing of the Purchase Agreement, Leveljump will own directly and indirectly, a 35.99% interest in RTM.

Closing of the Purchase Agreement and the issuance of the Consideration Shares is subject to the acceptance of the TSX Venture Exchange. For further information regarding the Company's interest in RTM, please see the Company's news releases dated November 25, 2021, December 29, 2021 and February 15, 2022.

About Leveljump Healthcare

Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J), is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler, Chief Executive Officer
[email protected]
(833) 840-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/121758